Page last updated: 2024-11-05

ticlopidine and Overweight

ticlopidine has been researched along with Overweight in 2 studies

Ticlopidine: An effective inhibitor of platelet aggregation commonly used in the placement of STENTS in CORONARY ARTERIES.
ticlopidine : A thienopyridine that is 4,5,6,7-tetrahydrothieno[3,2-c]pyridine in which the hydrogen attached to the nitrogen is replaced by an o-chlorobenzyl group.

Overweight: A status with BODY WEIGHT that is above certain standards. In the scale of BODY MASS INDEX, overweight is defined as having a BMI of 25.0-29.9 kg/m2. Overweight may or may not be due to increases in body fat (ADIPOSE TISSUE), hence overweight does not equal over fat.

Research Excerpts

ExcerptRelevanceReference
"Overweight or obese patients exhibit poorer platelet responses to clopidogrel."8.12Is platelet responsiveness to clopidogrel attenuated in overweight or obese patients and why? A reverse translational study in mice. ( Ge, PX; Ji, JZ; Jiang, LP; Li, YF; Mi, QY; Tai, T; Xie, HG; Zhu, T, 2022)
"Overweight or obese patients exhibit poorer platelet responses to clopidogrel."4.12Is platelet responsiveness to clopidogrel attenuated in overweight or obese patients and why? A reverse translational study in mice. ( Ge, PX; Ji, JZ; Jiang, LP; Li, YF; Mi, QY; Tai, T; Xie, HG; Zhu, T, 2022)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Puccini, M1
Rauch, C1
Jakobs, K1
Friebel, J1
Hassanein, A1
Landmesser, U1
Rauch, U1
Jiang, LP1
Ji, JZ1
Ge, PX1
Zhu, T1
Mi, QY1
Tai, T1
Li, YF1
Xie, HG1

Other Studies

2 other studies available for ticlopidine and Overweight

ArticleYear
Being Overweight or Obese Is Associated with an Increased Platelet Reactivity Despite Dual Antiplatelet Therapy with Aspirin and Clopidogrel.
    Cardiovascular drugs and therapy, 2023, Volume: 37, Issue:4

    Topics: Adenosine; Adenosine Diphosphate; Aspirin; Blood Platelets; Clopidogrel; Humans; Obesity; Overweight

2023
Is platelet responsiveness to clopidogrel attenuated in overweight or obese patients and why? A reverse translational study in mice.
    British journal of pharmacology, 2022, Volume: 179, Issue:1

    Topics: Animals; Blood Platelets; Clopidogrel; Humans; Mice; Obesity; Overweight; Platelet Aggregation; Plat

2022